Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPA-IVM vs Standard IVM in PCOS/PCOM
NCT03921710Completed
- Sponsor
- My Duc Hospital
- Start
- Apr 2017
- Primary completion
- Oct 2018
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of c-type natriuretic peptide in infertility and polycystic ovary syndrome (PCOS) (2 arms), sponsored by My Duc Hospital. Primary endpoint: Live birth rate at 24 weeks. Started Apr 2017; status: completed.
02
Drugs
c-type natriuretic peptide
03
Conditions
infertilitypolycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT03921710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03921710.